BeStock  
Markets › Compare › EPRX vs CTMX

EPRX vs CTMX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
EPRX · Eupraxia Pharmaceuticals$7.78 ▲ 0.52%
CTMX · CytomX$2.55 ▼ 0.39%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

67101135169203Oct 9, '25Apr 9, '26Oct 7, '26
  • EPRX +25.7%
  • CTMX -26.1%

Head to head

MetricEPRXCTMX
Price$7.78$2.55
Change today▲ 0.52%▼ 0.39%
Market cap$514.05M$555.64M
Return, 3 months+12.6%-35.5%
Return, year to date+3.0%-40.1%
Return, 1 year+26.7%-24.3%
P/E (TTM)-7.6-4.5
P/B5.11.8
P/E percentile vs own 5y–25th
Dividend yield––
Revenue growth (YoY, latest qtr)–-92.4%
Net profit growth (YoY)–-13,319.5%
Gross margin––
Operating margin–-476.2%
Net margin–-435.2%
Return on equity–-37.8%
Analyst target vs. price+118.5%+419.6%
Analyst buy share100%100%
RSI (14)4932
30-day volatility94.3%72.2%
Max drawdown, 1 year-35.9%-62.2%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CTMX is the largest of the group by market value.
  • EPRX has returned the most over the past year.
  • EPRX carries the lowest trailing P/E.
  • CTMX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top